Newsfeeds - Spark Newswire

3 minute read

Bulls And Bears Of The Week: Amazon, Tesla, Apple, Meta And Why An Analyst Is Turning Less Positive On 2 Legacy Automakers

Today, 5:23 AM

Benzinga examined the prospects for many investors' favorite stocks over the past week — here's a look at some of our top stories.

AAPL

1 minute read

Why Pfizer Partner BioNTech SE Shares Are Trading Higher

By Henry Khederian

Today, 5:23 AM

BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by 5.37% to $136.45 going into the close of Wednesday's trading session after the FDA granted Emergency Use Authorization to the company's 10-µg booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine.

BNTX

1 minute read

FDA Says Both Moderna, Pfizer-BioNTech COVID-19 Vaccine Continue To Be Authorized For Primary Series Administration In Individuals 6 Months Of Age, Older

By Benzinga Newsdesk

Today, 5:23 AM

- Reuters

BNTX

1 minute read

FDA Authorizes Moderna And Pfizer-BioNTech Bivalent Covid-19 Vaccines For Use As A Booster Dose In Younger Age Groups

By Benzinga Newsdesk

Today, 5:23 AM

- Reuters

BNTX

1 minute read

Swissmedic Approves Bivalent COVID-19 Booster Vaccine From Pfizer

By Bill Haddad

Today, 5:23 AM

-Reuters

BNTX

1 minute read

Pfizer’s Partner BioNTech Signs Research Pact With Australia

By Vandana Singh

Today, 5:23 AM

Pfizer Inc’s (NYSE:PFE) COVID-19 partner BioNTech SE (NASDAQ:BNTX) will set up research and manufacturing centers in Australia. BioNTech and Australia’s Victoria state signed…

BNTX

1 minute read

As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster

By Vandana Singh

Today, 5:23 AM

The FDA authorized an additional five batches of Moderna Inc’s (NASDAQ:MRNA) updated Covid booster shots made at Catalent Inc‘s (NYSE:CTLT) Indiana facility after…

BNTX

2 minute read

Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges

By Vandana Singh

Today, 5:23 AM

Last week, Moderna Inc (NASDAQ: MRNA) said it asked the FDA to authorize the use of its updated booster shot in children ages 6 to 17. The company expects to complete a request for the use of the booster in children six months through 5 years later this year.

BNTX

1 minute read

News

French Health Authority Clears Omicron-Adapted Covid-19 Boosters For Autumn Vaccination Campaign

By Benzinga Newsdesk

Today, 5:23 AM

- Reuters

AZN

2 minute read

‘New York City Lifting Covid-19 Vaccine Mandate For Private Sector’ – Abc7NY

By Benzinga Newsdesk

Today, 5:23 AM

https://abc7ny.com/nyc-covid-mask-mandate-new-york-statistics/12242966/?ex_cid=TA_WABC_TW&taid=6329c8841c8e330001002b70&utm_campaign=trueAnthem:+New+Content+(Feed)&utm_medium=trueAnthem&utm_source

AZN